Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 6, 2018PharmacogenomicsOpen Access

Pharmacogenetic Tests and Depressive Symptom Remission: A Meta-Analysis of Randomized Controlled Trials

View Full Paper
Ask AI
Bookmark
Share

Authors

CBChad BousmanAllen Institute for Brain ScienceKAKatarina ArandjelovicThe Royal Melbourne HospitalSMSerafino G. MancusoThe University of Melbourne

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Bousman et al. (2018) studied this question.

synapsesocial.com/papers/6a157fe89b87f33fc69f9ccbhttps://doi.org/10.2217/pgs-2018-0142
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders2015 · 864 citations
  2. 2Acute and Longer-Term Outcomes in Depressed Outpatients Requiring One or Several Treatment Steps: A STAR*D Report2006 · 5,680 citations
  3. 3Remission with mirtazapine and selective serotonin reuptake inhibitors: a meta-analysis of individual patient data from 15 controlled trials of acute phase treatment of major depression2010 · 90 citations
  4. 4Using a pharmacogenomic algorithm to guide the treatment of depression2012 · 183 citations
  5. 5PREDICTIVE SOCIOECONOMIC AND CLINICAL PROFILES OF ANTIDEPRESSANT RESPONSE AND REMISSION2013 · 58 citations